Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 — amends Medicare and ERISA to create requirements for pharmacy.
The Net Effective Cost Transparency and Prescription Drug Affordability Act of 2026 amends title XVIII of the Social Security Act and the Employee Retirement Income Security Act of 1974 to establish requirements for pharmacy benefit managers. It mandates a standardized public bidding process for pharmacy benefit managers, requiring them to provide detailed information in their bids, including projected net effective costs and guarantees regarding cost transparency.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.